Elsibucol - CAS 216167-95-2
Catalog number: 216167-95-2
Category: Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
Molecular Weight:
Elsibucol, a metabolically stable derivative of probucol, inhibits atherosclerosis and preserves endothelial healing following arterial injury. In vitro, elsibucol reduces vascular smooth muscle cell proliferation without affecting cell viability.
Publictions citing BOC Sciences Products
  • >> More
Solid powder
4-[2,6-ditert-butyl-4-[2-(3,5-ditert-butyl-4-hydroxyphenyl)sulfanylpropan-2-ylsulfanyl]phenoxy]butanoic acid; (4,2,6-di-tert-butyl-4-(1-(3,5-di-tert-butyl-4-hydroxy-phenylsulfanyl)-1-methyl-ethylsulfanyl)-phenoxy-butyric acid); AGI-1096; elsibucol
Canonical SMILES:
1.Lead acetate induces EGFR activation upstream of SFK and PKCalpha linkage to the Ras/Raf-1/ERK signaling.
Wang CY1, Wang YT, Tzeng DW, Yang JL. Toxicol Appl Pharmacol. 2009 Mar 1;235(2):244-52. doi: 10.1016/j.taap.2008.12.007. Epub 2008 Dec 24.
Lead acetate (Pb), a probable human carcinogen, can activate protein kinase C (PKC) upstream of extracellular signal-regulated kinase 1 and 2 (ERK1/2). Yet, it remains unclear whether Pb activation of PKC --> ERK1/2 involves receptor/non-receptor tyrosine kinases and the Ras signaling transducer. Here we demonstrate a novel mechanism elicited by Pb for transmitting ERK1/2 signaling in CL3 human non-small-cell lung adenocarcinoma cells. Pb induction of higher steady-state levels of Ras-GTP was essential for increasing phospho-Raf-1(S338) and phospho-ERK1/2. Pre-treatment of the cells with a conventional PKC inhibitor Gö6976 or depleting PKCalpha using specific small interfering RNA blocked Pb induction of Ras-GTP. Pb also activated cellular tyrosine kinases. Specific pharmacological inhibitors, PD153035 for epidermal growth factor receptor (EGFR) and SU6656 for Src family tyrosine kinases (SFK), but not AG1296 for platelet-derived growth factor receptor, could suppress the Pb-induced tyrosine kinases, PKCalpha, Ras-GTP, phospho-Raf-1(S338) and phospho-ERK1/2.
2.Effects of AGI-1096, a novel antioxidant compound with anti-inflammatory and antiproliferative properties, on rodent allograft arteriosclerosis.
Murata S1, Sundell CL, Lijkwan MA, Balsam LB, Hammainen P, Coleman C, York C, Luchoomun J, Suen KL, Howard R, Somers PK, Morris RE, Robbins RC. Transplantation. 2004 May 27;77(10):1494-500.
BACKGROUND: AGI-1096 is a novel phenolic intracellular antioxidant with anti-inflammatory and antiproliferative properties. In vitro, AGI-1096 inhibited the inducible expression of vascular cell adhesion molecule (VCAM)-1, E-selectin, and monocyte chemoattractant protein (MCP)-1 in endothelial cells and tumor necrosis factor (TNF)-alpha and interleukin (IL)-1beta secretion from lipopolysaccharide (LPS)-stimulated peripheral blood mononuclear cells. It also inhibited serum-stimulated proliferation of aortic smooth-muscle cells. In vivo, AGI-1096 demonstrated anti-inflammatory properties in a murine delayed-type hypersensitivity model. Given these antioxidant, anti-inflammatory and antiproliferative properties, we reasoned that AGI-1096 may be able to prevent chronic allograft arteriosclerosis. This hypothesis was tested in a rodent aortic transplantation model.
3.Elsibucol inhibits atherosclerosis following arterial injury: multifunctional effects on cholesterol levels, oxidative stress and inflammation.
Dussault S1, Dhahri W1, Desjarlais M1, Mathieu R1, Rivard A2. Atherosclerosis. 2014 Nov;237(1):194-9. doi: 10.1016/j.atherosclerosis.2014.09.008. Epub 2014 Sep 16.
BACKGROUND: Elsibucol is a metabolically stable derivative of probucol with antioxidant, anti-inflammatory and antiproliferative properties. Here we investigated the effect of elsibucol on the development of atherosclerosis following arterial injury in hypercholesterolemic rabbits.
4.Helicobacter pylori seroprevalence in patients with chronic obstructive pulmonary disease and its relation to pulmonary function tests.
Gencer M1, Ceylan E, Yildiz Zeyrek F, Aksoy N. Respiration. 2007;74(2):170-5. Epub 2005 Dec 6.
BACKGROUND: Chronic obstructive pulmonary disease (COPD) is a slowly progressive condition characterized by poorly reversible airflow limitation that is associated with an abnormal inflammatory response of the lung. It has been shown that there is a seroepidemiological association of Helicobacter pylori (Hp) infection with many inflammatory conditions.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Products

CAS 269730-03-2 RPI-1

(CAS: 269730-03-2)

RPI-1 is a cell-permeable, ATP-dependent RET kinase inhibitor. Oral treatment with RPI-1 caused growth arrest or regression in 81% treated tumors. It can also b...

CAS 141195-77-9 Cefovecin sodium

Cefovecin sodium
(CAS: 141195-77-9)

Cefovecin Sodium is an antibiotic of the cephalosporin class. It is used for the treatment of skin infections caused by Pasturella multocida in cats, and Staphy...

JNJ 42396302
(CAS: 1298030-18-8)

JNJ 42396302 is an Antipsychotics originated by Janssen-Cilag. But no development has been reported yet.

CAS 557-08-4 Zinc undecylenate

Zinc undecylenate
(CAS: 557-08-4)

Zinc undecylenate is a ungistatic fatty acid used in creams against fungal infections, eczemas, ringworm, and other cutaneous conditions.

SV40 large T antigen NLS

SV40 large T antigen NLS, a hexamer protein generated from Large T antigen residue 47 to 55, enables protein import into cell nucleus.

CAS 29053-27-8 Meseclazone

(CAS: 29053-27-8)

Meseclazone, a nonsteroidal anti-inflammatory drug (NSAID), exhibits inhibitory potency of secondary phase ADP aggregation.

(CAS: 191866-32-7)

BMS-188494 is the prodrug of BMS-187745, a squalene synthase inhibitor used as an anticholesterol drug.

CAS 223666-07-7 Collagen proline hydroxylase inhibitor

Collagen proline hydroxylase inhibitor
(CAS: 223666-07-7)

Collagen proline hydroxylase inhibitor is a collagen proline hydroxylase inhibitor; useful for antifibroproliferative agents.

CAS 520-18-3 Kaempferol

(CAS: 520-18-3)

Kaempferol is a natural flavonol, a type of flavonoid, that has been isolated from plant sources.

CAS 76901-59-2 Speract

(CAS: 76901-59-2)

Speract, a peptide associated with eggs of sea urchin, Lytechinus pictus, regulates sperm motility, also stimulates sperm mitochondrial metabolism.

CAS 93265-81-7 Ropidoxuridine

(CAS: 93265-81-7)

Ropidoxuridine is a novel, orally available 5-substituted 2-pyrimidinone-2'-deoxyribonucleoside analogue and prodrug of 5-iododeoxyuridine (IUdR). It has radios...

CAS 6880-91-7 Dihydrochelerythrine

(CAS: 6880-91-7)

Dihydrochelerythrine is a natural compound isolated from the leaves of Macleaya microcarpa, which has antifungal activity.

CAS 840-80-2 Acroteben

(CAS: 840-80-2)

Acroteben is a bio-active chemical but no detailed information has been published yet.

CAS 106635-80-7 Tafenoquine

(CAS: 106635-80-7)

Tafenoquine is an oral active and an 8-aminoquinoline antimalaria drug. It is being investigated as a potential treatment for malaria, as well as for malaria pr...

CAS 479-92-5 Isopropylantipyrinum

(CAS: 479-92-5)

Isopropylantipyrinum is a derivative of phenazone with similar analgesic and antipyretic effects.

CAS 178925-65-0 APC-366

(CAS: 178925-65-0)

APC-366, an amino acid derivative, has been found to be a mast cell tryptase inhibitor and was once studied against asthma by Celera Genomics Group. Ki: 7.1 μM.

CAS 127967-03-7 PD 131628

PD 131628
(CAS: 127967-03-7)

PD 131628 is a new fluoroquinolone as the bioactive form of PD 131112 which is a antibacterial agent originated by Pfizer. PD 131112 can be used for the treatme...

CAS 52-21-1 Prednisolone Acetate

Prednisolone Acetate
(CAS: 52-21-1)

Prednisolone Acetate is a synthetic corticosteroid drug that is particularly effective as an immunosuppressant agent.

CAS 229476-53-3 EBE-A22

(CAS: 229476-53-3)

The brominated anilinoquinazoline derivative PD153035 exhibits a very high affinity and selectivity for the epidermal growth factor receptor tyrosine kinase (EG...

CAS 143748-18-9 PACAP 6-38

PACAP 6-38
(CAS: 143748-18-9)

PACAP 6-38 is a PACAP (pituitary adenylate cyclase-activating polypeptide) non-stimulating competitive antagonist (IC50= 2 nM), with antitumor activity in vivo....

Chemical Structure

CAS 216167-95-2 Elsibucol

Quick Inquiry

Verification code

Featured Items